http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004241695-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43504 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 |
filingDate | 2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e2db96c96912f3a74d10249836d6ac5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b14e564994328b0cdcb468a2ebff7d1e |
publicationDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004241695-A1 |
titleOfInvention | Hemocyanin nucleic acids and polypeptides and related vectors fusion protein conjugates cells and methods of use |
abstract | An isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence encoding KLH or a fragment thereof, as well as an isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence complementary thereto; a vector comprising such a nucleic acid, optionally as part of an encoded fusion protein when the nucleic acid encodes KLH or a fragment thereof; a cell comprising and expressing an above-described nucleic acid, optionally in the form of a vector; an isolated or purified polypeptide molecule consisting essentially of an amino acid sequence encoding KLH-1, KLH-2, or a fragment of either of the foregoing, as well as a conjugate or fusion protein comprising the same and a therapeutically or prophylactically active agent, and related compositions; a method of treating cancer, pathogenic infection, and high blood pressure in a mammal; methods of stimulating an immune response in a mammal; a method of identifying an immunogenic portion of KLH, and an isolated or purified nucleic acid molecule consisting essentially of a nucleotide sequence encoding the leader sequence of KLH-1 or KLH-2, optionally coupled 5′ to an isolated or purified nucleic acid molecule encoding a polypeptide or protein, in which case the nucleic acid is optionally in the form of a vector, as well as a eukaryotic cell comprising and expressing same. |
priorityDate | 2001-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1122.